Market closedNon-fractional

Recursion Pharmaceuticals/RXRX

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Recursion Pharmaceuticals

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Ticker

RXRX

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Salt Lake City, United States

Employees

500

RXRX Metrics

BasicAdvanced
$1.9B
Market cap
-
P/E ratio
-$1.62
EPS
0.85
Beta
-
Dividend rate
$1.9B
0.85
4.648
4.044
11.182
12.707
-3,853.02%
-39.82%
-85.19%
33.91
4.24
5.39
-4.74
-0.88%
17.50%
92.67%
-28.83%

What the Analysts think about RXRX

Analyst Ratings

Majority rating from 7 analysts.
Hold

RXRX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-666.42% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$14M
26.85%
Net income
-$91M
-1.72%
Profit margin
-666.42%
-22.53%

RXRX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 7.87%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.38
-$0.43
-$0.42
-$0.39
-
Expected
-$0.37
-$0.39
-$0.45
-$0.42
-$0.41
Surprise
1.53%
11.69%
-6.41%
-7.87%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Recursion Pharmaceuticals stock?

Recursion Pharmaceuticals (RXRX) has a market cap of $1.9B as of July 05, 2024.

What is the P/E ratio for Recursion Pharmaceuticals stock?

The price to earnings (P/E) ratio for Recursion Pharmaceuticals (RXRX) stock is 0 as of July 05, 2024.

Does Recursion Pharmaceuticals stock pay dividends?

No, Recursion Pharmaceuticals (RXRX) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Recursion Pharmaceuticals dividend payment date?

Recursion Pharmaceuticals (RXRX) stock does not pay dividends to its shareholders.

What is the beta indicator for Recursion Pharmaceuticals?

Recursion Pharmaceuticals (RXRX) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Recursion Pharmaceuticals stock

Buy or sell Recursion Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing